Author:
Ly Bevan H.,Nguyen Nam P.,Vinh-Hung Vincent,Rapiti Elisabetta,Vlastos Georges
Publisher
Springer Science and Business Media LLC
Reference34 articles.
1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, Thun MJ (2008) Cancer statistics. CA Cancer J Clin 58(2):71–96
2. Ries LAG, Melbert D, Krapcho M et al. (eds) SEER cancer statistics review, 1975–2004. National Cancer Institute, Bethesda. http://seer.cancer.gov/csr/1975_2004/ , based on November 2006 SEER data submission, posted to the SEER Web site, 2007 gotten from the ACS Breast Cancer Facts
3. Biron P, Durand M, Roche H, Delozier T, Battista C, Fargeot P, Spaeth D, Bachelot T, Poiget E, Monnot F, Tanguy ML, Cure H (2008) Pegase 03: a prospective randomized phase III trial of FEC with or without high dose thiotepa, cyclophosphamide and autologous stem cell transplantation in first line treatment of metastatic breast cancer. Bone Marrow Transplant 41:555–562
4. Chuthapisit S, Eremin J, El-Sheemey M, Eremin O (2009) Breast cancer chemoresistance: emerging importance of cancer stem cells. Surg Oncol [Epub ahead of print]
5. Dean M, Fojo T, Bates S (2005) Tumor stem cells and drug resistance. Nat Rev Cancer 5:275–284
Cited by
41 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献